NEW YORK, June 22 (GenomeWeb News) - Shares of Orchid Cellmark dropped $1.30, or 35.1 percent, to $2.40 in afternoon trading after the company said its first-quarter revenues declined 14 percent and losses increased.
...and receive Daily News bulletins.
Already have an account?Login Now.
Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.
Genetic genealogy has led to an arrest in another cold case, dating back to 1987.
In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.
Wired reports that 23andMe is trying to bolster its outside collaborations.